Castleview Partners’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
Other funds holding CL
Castleview Partners's CL Position: Q3 2026 in Review
Castleview Partners held its Colgate-Palmolive (CL) position steady in Q3 2026 at 4,537 shares worth $387K. The position accounts for 0.17% of the portfolio, ranked #140.
Castleview Partners first reported a position in CL in Q2 2021 and has held it in 18 quarters since. The position peaked at $416K in Q2 2026. 457 funds tracked by Wall St. Rank hold CL as of Q3 2026.
- Castleview Partners held 4,537 shares of Colgate-Palmolive worth $387K as of Q3 2026.
- Castleview Partners left its Colgate-Palmolive share count unchanged in Q3 2026.
- Colgate-Palmolive made up 0.17% of Castleview Partners's portfolio in Q3 2026, its #140 holding.
- Castleview Partners first reported a position in Colgate-Palmolive in Q2 2021 and has held it in 18 quarters since.
- Castleview Partners's Colgate-Palmolive position peaked at $416K in Q2 2026.
- 457 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.
Based on Castleview Partners's 13F filing for Q3 2026, filed 9 Oct 2026.